PERTH, Australia, Jan. 26, 2022 /PRNewswire/ -- Advanced
Human Imaging Limited (ASX: AHI) (NASDAQ: AHI) ("AHI" or the
"Company") is pleased to announce the signing of a binding term
sheet with Activate Health OÜ ("Activate"), an
Estonia-based digital health
provider.
Activate is developing a digital therapeutic platform for the
prevention and early intervention of metabolic syndrome, a silent
epidemic that effects nearly a third of the world's adult
population. The digital therapeutic platform will provide patients
and specialists with the necessary tools to address metabolic
syndrome and delay the onset of chronic diseases such as
cardiovascular disease and type 2 diabetes.
Activate will integrate the AHI MultiScan Software Development
Kit into its proprietary digital therapeutic platform. The
integration will empower users of the Activate platform to track
and ascertain dimensional-based risk assessments, vital signs and
identify chronic disease risk. These data points will be used to
support and improve Activate health audits, targeted
micro-programs, and on-demand appointments with healthcare
specialists.
"We are delighted to be involved with such an innovative company
that is based in the most progressive and advanced digital health
ecosystem in the world, Estonia,"
said Vlado Bosanac, Chief Executive Officer of Advanced Human
Imaging. "Our MultiScan solution enables our partners to intervene
and assist their users early. Not only does this result in better
health outcomes, but it improves the cost-effectiveness and
facilitates the transition to preventive, rather than curative,
medicine. We look forward to making a positive impact on Europeans'
longevity of life, health and wellbeing."
Siim Saare, Founder and Chief
Executive Officer of Activate Health, commented: "We are extremely
excited to be working with AHI and to integrate their solution into
the Activate platform application. The AHI technology will assist
in the development of the novel health risk prediction model and
AI-driven decision support system for the prevention and early
intervention of chronic disease."
In January 2022 Activate was
awarded a grant by Enterprise Estonia to expand their digital
health footprint. This grant will assist in the acceleration of the
integration of the AHI MultiScan digital health solution.
About Advanced Human Imaging:
AHI has developed and patented a proprietary dimensioning
technology that enables its users to check, track, and assess their
dimensions in conjunction with known health risk indicators using
only a smartphone both privately and accurately.
Our goal is to assist our partners by empowering their consumers
with this capability. This in return gives our partners the ability
to assess, assist, and communicate outcomes with their consumers
when navigating day to day life. Whether this is a personal journey
to better health, understanding the risk associated with their
physical condition, tracking the changes they are experiencing
through training, dieting, or under medical regimes, or simply
wanting to be correctly sized for a garment when shopping online.
The AHI technology delivers this seamlessly, privately, and
cost-effectively in under one minute.
AHI has developed this capability by leveraging the power of
Computer Vision, Machine Learning, and patented algorithms, to
process the images and assessments on secure, enterprise-level
infrastructure, delivering an end–to–end experience that is
unrivalled in the industry. AHI simplifies the collection of
measurements and removes the human error present in traditional
methods.
Forward Looking Statements
This press release contains certain forward-looking statements,
including those relating to the regarding the use of proceeds and
other statements that are predictive in nature. Forward-looking
statements are based on the Company's current expectations and
assumptions. The Private Securities Litigation Reform Act of 1995
provides a safe-harbor for forward-looking statements. These
statements may be identified by the use of forward-looking
expressions, including, but not limited to, 'expect,' 'anticipate,'
'intend,' 'plan,' 'believe,' 'estimate,' 'potential,' 'predict,'
'project,' 'should,' 'would' and similar expressions and the
negatives of those terms. Prospective investors are cautioned not
to place undue reliance on such forward-looking statements, which
speak only as of the date of this presentation. The Company
undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Important factors that could cause actual results to
differ materially from those in the forward-looking statements are
set forth in the Company's filings with the Securities and Exchange
Commission, including its registration statement on Form F-1, as
amended from time to time, under the caption 'Risk Factors.'
For more information please
visit: www.advancedhumanimaging.com
For more information contact:
Vlado
Bosanac,
|
For media
inquiries:
|
Chief Executive
Officer
|
Nic
Johnson
|
Advanced Human
Imaging Limited
|
Russo
Partners
|
E: admin@advancedhumanimaging.com
|
E: nic.johnson@russopartnersllc.com
|
|
+1 (212)
845-4242
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/advanced-human-imaging-signs-partnership-with-activate-health-ou-301468647.html
SOURCE Advanced Human Imaging